BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 29107620)

  • 1. Lacking quality in research: Is behavioral neuroscience affected more than other areas of biomedical science?
    Bespalov A; Steckler T
    J Neurosci Methods; 2018 Apr; 300():4-9. PubMed ID: 29107620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardized and reproducible measurement of decision-making in mice.
    ; Aguillon-Rodriguez V; Angelaki D; Bayer H; Bonacchi N; Carandini M; Cazettes F; Chapuis G; Churchland AK; Dan Y; Dewitt E; Faulkner M; Forrest H; Haetzel L; Häusser M; Hofer SB; Hu F; Khanal A; Krasniak C; Laranjeira I; Mainen ZF; Meijer G; Miska NJ; Mrsic-Flogel TD; Murakami M; Noel JP; Pan-Vazquez A; Rossant C; Sanders J; Socha K; Terry R; Urai AE; Vergara H; Wells M; Wilson CJ; Witten IB; Wool LE; Zador AM
    Elife; 2021 May; 10():. PubMed ID: 34011433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Avoiding Beach's Boojum Effect: Enhancing bench to bedside translation with field to laboratory considerations in optimal animal models.
    Lambert K; Kent M; Vavra D
    Neurosci Biobehav Rev; 2019 Sep; 104():191-196. PubMed ID: 31278952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tackling reproducibility in academic preclinical drug discovery.
    Frye SV; Arkin MR; Arrowsmith CH; Conn PJ; Glicksman MA; Hull-Ryde EA; Slusher BS
    Nat Rev Drug Discov; 2015 Nov; 14(11):733-4. PubMed ID: 26388229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Removing obstacles in neuroscience drug discovery: the future path for animal models.
    Markou A; Chiamulera C; Geyer MA; Tricklebank M; Steckler T
    Neuropsychopharmacology; 2009 Jan; 34(1):74-89. PubMed ID: 18830240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The practice of theoretical neuroscience.
    Nat Neurosci; 2005 Dec; 8(12):1627. PubMed ID: 16306884
    [No Abstract]   [Full Text] [Related]  

  • 7. Considering Sex as a Biological Variable Will Be Valuable for Neuroscience Research.
    Shansky RM; Woolley CS
    J Neurosci; 2016 Nov; 36(47):11817-11822. PubMed ID: 27881768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NIMH Drug Trials for Schizophrenia.
    Torrey EF; Yolken RH; Lamb HR
    J Clin Psychiatry; 2019 Jan; 80(1):. PubMed ID: 30677268
    [No Abstract]   [Full Text] [Related]  

  • 9. The structure of non-human cognitive neuroscience: an epistemological critique.
    Almeida F
    Rev Neurosci; 2019 Nov; 30(8):881-888. PubMed ID: 31129657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of restorative neurosciences in stroke: driving the translational research pipeline from basic science to rehabilitation of people after stroke.
    ; Cheeran B; Cohen L; Dobkin B; Ford G; Greenwood R; Howard D; Husain M; Macleod M; Nudo R; Rothwell J; Rudd A; Teo J; Ward N; Wolf S
    Neurorehabil Neural Repair; 2009 Feb; 23(2):97-107. PubMed ID: 19189939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The preclinical data forum network: A new ECNP initiative to improve data quality and robustness for (preclinical) neuroscience.
    Steckler T; Brose K; Haas M; Kas MJ; Koustova E; Bespalov A;
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1803-7. PubMed ID: 26073278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Costs of Reproducibility.
    Poldrack RA
    Neuron; 2019 Jan; 101(1):11-14. PubMed ID: 30605654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of behavioural bioassays in neuroscience.
    Brown RE; Bolivar S
    J Neurosci Methods; 2018 Apr; 300():68-76. PubMed ID: 28552516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical issues associated with the use of animal experimentation in behavioral neuroscience research.
    Ohl F; Meijboom F
    Curr Top Behav Neurosci; 2015; 19():3-15. PubMed ID: 25023419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-brain barrier models: in vitro to in vivo translation in preclinical development of CNS-targeting biotherapeutics.
    Stanimirovic DB; Bani-Yaghoub M; Perkins M; Haqqani AS
    Expert Opin Drug Discov; 2015 Feb; 10(2):141-55. PubMed ID: 25388782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diversity and representation: Key issues for psychophysiological science.
    Gatzke-Kopp LM
    Psychophysiology; 2016 Jan; 53(1):3-13. PubMed ID: 26681612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reproducibility issue and preclinical academic drug discovery: educational and institutional initiatives fostering translation success.
    Janero DR
    Expert Opin Drug Discov; 2016 Sep; 11(9):835-42. PubMed ID: 27401809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A physiologically based modeling strategy during preclinical CNS drug development.
    Ball K; Bouzom F; Scherrmann JM; Walther B; Declèves X
    Mol Pharm; 2014 Mar; 11(3):836-48. PubMed ID: 24446829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. True alignment of preclinical and clinical research to enhance success in CNS drug development: a review of the current evidence.
    Goetghebeur PJ; Swartz JE
    J Psychopharmacol; 2016 Jul; 30(7):586-94. PubMed ID: 27147593
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.